Technical Analysis for HUGE - FSD Pharma Inc. - Class B Subordinate Voting Shares
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 0.47 | 0.28% | 0.00 |
HUGE closed up 0.28 percent on Friday, April 19, 2024, on 26 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 10
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Boomer Sell Setup | Bearish Swing Setup | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.28% | |
Inside Day | Range Contraction | 0.28% | |
Wide Bands | Range Expansion | 0.28% | |
Below Lower BB | Weakness | 0.28% | |
Gapped Down | Weakness | 0.28% |
Alert | Time |
---|---|
Possible Inside Day | about 20 hours ago |
Down 2 % | about 21 hours ago |
60 Minute Opening Range Breakout | about 23 hours ago |
Up 2% | about 23 hours ago |
Up 1% | about 23 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/10/2024
FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, GI tract, and musculoskeletal system, such as chronic pain. FSD Pharma Inc. has strategic alliance agreements with SciCann Therapeutics Inc., CannTab Therapeutics, and Solarvest BioEnergy Inc. The company was founded in 1998 and is headquartered in Cobourg, Canada.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Health Sciences Autoimmune Disease Cannabis Chronic Pain Central Nervous System Disorders Nervous System Disorders Medical Cannabis Bioenergy Cannabis In Canada Cannabinoid Skeletal System Antiemetics Musculoskeletal System Antioxidants
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Health Sciences Autoimmune Disease Cannabis Chronic Pain Central Nervous System Disorders Nervous System Disorders Medical Cannabis Bioenergy Cannabis In Canada Cannabinoid Skeletal System Antiemetics Musculoskeletal System Antioxidants
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.6799 |
52 Week Low | 0.4184 |
Average Volume | 164,678 |
200-Day Moving Average | 1.03 |
50-Day Moving Average | 0.75 |
20-Day Moving Average | 0.61 |
10-Day Moving Average | 0.55 |
Average True Range | 0.05 |
RSI (14) | 17.36 |
ADX | 43.82 |
+DI | 6.22 |
-DI | 38.68 |
Chandelier Exit (Long, 3 ATRs) | 0.58 |
Chandelier Exit (Short, 3 ATRs) | 0.57 |
Upper Bollinger Bands | 0.78 |
Lower Bollinger Band | 0.45 |
Percent B (%b) | 0.06 |
BandWidth | 53.88 |
MACD Line | -0.08 |
MACD Signal Line | -0.06 |
MACD Histogram | -0.0129 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.50 | ||||
Resistance 3 (R3) | 0.50 | 0.49 | 0.50 | ||
Resistance 2 (R2) | 0.49 | 0.48 | 0.49 | 0.50 | |
Resistance 1 (R1) | 0.48 | 0.48 | 0.48 | 0.48 | 0.49 |
Pivot Point | 0.47 | 0.47 | 0.47 | 0.47 | 0.47 |
Support 1 (S1) | 0.45 | 0.46 | 0.46 | 0.45 | 0.44 |
Support 2 (S2) | 0.44 | 0.45 | 0.44 | 0.44 | |
Support 3 (S3) | 0.43 | 0.44 | 0.44 | ||
Support 4 (S4) | 0.43 |